Publications by authors named "Xiangdan Cuan"

Claim this Profile
N
Network Pharmacology Approach and Experimental Verification to Explore the Anti-NSCLC Mechanism of Grifolic Acid.
Xiangdan Cuan, Jinxian Wang, Yue Zhao, Jingyun Yan, Jun Sheng

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1/2 pathway.
Xiangdan Cuan, Xingying Yang, Jinxian Wang, Jun Sheng, Xuanjun Wang

Bioorg Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC.
Yanping Huang, Xiangdan Cuan, Weiwei Zhu, Xingying Yang, Yunli Zhao

Int J Mol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of erlotinib in combination with berberine in A431 cells.
Xiangdan Cuan, Xingying Yang, Weiwei Zhu, Yue Zhao, Rui Luo

BMC Pharmacol Toxicol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized tea polyphenol (OTP-3) targets EGFR synergistic nimotuzumab at inhibition of non-small cell lung tumor growth.
Yanping Huang, Xiangdan Cuan, Xingying Yang, Weiwei Zhu, Yunli Zhao

Bioorg Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis .
Titi Liu, Shihua Ding, Dan Yin, Xiangdan Cuan, Chuanqi Xie

Front Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis